# DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device

> **NCT05543447** · — · RECRUITING · sponsor: **Acandis GmbH** · enrollment: 158 (estimated)

## Conditions studied

- Intracranial Aneurysm
- Flow Diverter

## Interventions

- **DEVICE:** Flow Diverter Treatment with DERIVO 2 Heal Embolisation Device

## Key facts

- **NCT ID:** NCT05543447
- **Lead sponsor:** Acandis GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-15
- **Primary completion:** 2025-12
- **Final completion:** 2026-12
- **Target enrollment:** 158 (ESTIMATED)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05543447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05543447, "DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05543447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*